Evidence map›Paper›PMID 36137075›Full record

ArticlePLoS genetics2022

The impact of Mendelian sleep and circadian genetic variants in a population setting.

Michael N Weedon, Samuel E Jones, Jacqueline M Lane, Jiwon Lee, Hanna M Ollila, Amy Dawes, Jess Tyrrell, Robin N Beaumont, Timo Partonen, Ilona Merikanto and 8 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Emerging genetics of sleep and circadian disorders.Current opinion in pediatrics · 2026
    Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 3 countries.

Michael N WeedonGenetics of Complex Traits, College of Medicine and Health, University of Exeter, Exeter, Devon, United Kingdom.ORCID 0000-0002-6174-6135
Samuel E JonesGenetics of Complex Traits, College of Medicine and Health, University of Exeter, Exeter, Devon, United Kingdom.ORCID 0000-0003-0153-922X
Jacqueline M LaneCenter for Genomic Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
Jiwon LeeDivision of Sleep and Circadian Disorders, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Hanna M OllilaInstitute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-5302-6429
Amy DawesGenetics of Complex Traits, College of Medicine and Health, University of Exeter, Exeter, Devon, United Kingdom.ORCID 0000-0003-0920-9428
Jess TyrrellGenetics of Complex Traits, College of Medicine and Health, University of Exeter, Exeter, Devon, United Kingdom.ORCID 0000-0002-9256-6065
Robin N BeaumontGenetics of Complex Traits, College of Medicine and Health, University of Exeter, Exeter, Devon, United Kingdom.
Timo PartonenDepartment of Public Health Solutions, Finnish Institute for Health and Welfare, Helsinki, Finland.ORCID 0000-0003-1951-2455
Ilona MerikantoDepartment of Public Health Solutions, Finnish Institute for Health and Welfare, Helsinki, Finland.ORCID 0000-0002-1222-6678
Stephen S RichCenter for Public Health Genomics, Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, United States of America.ORCID 0000-0003-3872-7793
Jerome I RotterInstitute for Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation, Torrance, California, United States of America.ORCID 0000-0001-7191-1723
Timothy M FraylingGenetics of Complex Traits, College of Medicine and Health, University of Exeter, Exeter, Devon, United Kingdom.
Martin K RutterDivision of Diabetes, Endocrinology and Gastroenterology, Faculty of Medicine, Biology and Health, University of Manchester, Manchester, United Kingdom.
Susan RedlineDivision of Sleep and Circadian Disorders, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.ORCID 0000-0002-6585-1610
Tamar SoferDivision of Sleep and Circadian Disorders, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.ORCID 0000-0001-8520-8860
Richa SaxenaCenter for Genomic Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
Andrew R WoodGenetics of Complex Traits, College of Medicine and Health, University of Exeter, Exeter, Devon, United Kingdom.ORCID 0000-0003-1726-948X
University of Exeter · GBBrigham and Women's Hospital · USBroad Institute · USUniversity of Helsinki · FIFinnish Institute for Health and Welfare · FIManchester Academic Health Science Centre · GBOffice of Public Health Genomics · USUCLA Medical Center · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PETER J TONTONOZ · 2003 to 2026
$40.4M
ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI ALEXANDER A SOUKAS · 1994 to 2026
$31.6M
Phenotypic and Molecular Signatures for Sleep Apnea and Related MorbiditiesR35HL135818 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI REDLINE, SUSAN S. · 2017 to 2023
$7.2M
Dissecting Causal Role of Insomnia in Cardiovascular DiseaseR01HL146751 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MELKANI, GIRISH C., SAXENA, RICHA · 2020 to 2023
$3.6M
Leveraging human genetics to overcome complex diagnostic challenges, evaluation of pan-ancestry polygenic scores to reduce misdiagnosis of narcolepsy and circadian rhythm sleep wake disorders.R01HG012810 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI Daniel J Gottlieb · 2023 to 2026
$2.6M
Genetics of human circadian rhythms: using sequencing, novel phenotyping methods, and functional assays to move towards a deeper understanding of circadian mechanismsR35GM146839 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI LANE, JACQUELINE MARIE · 2022 to 2025
$1.8M
Genetic and molecular basis of circadian rhythm disordersK01HL136884 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI LANE, JACQUELINE MARIE · 2018 to 2022
$848k
British Heart Foundation SBF006\1134Medical Research Council MC_PC_17228Medical Research Council MC_QA137853Medical Research Council MR/M005070/1Medical Research Council MR/P012167/1Medical Research Council MR/T00200X/1NCATS NIH HHS UL1 TR001881NHGRI NIH HHS R01 HG012810NHLBI NIH HHS K01 HL136884NHLBI NIH HHS R01 HL146751NHLBI NIH HHS R35 HL135818NIDDK NIH HHS P30 DK040561NIDDK NIH HHS P30 DK063491NIGMS NIH HHS R35 GM146839Wellcome Trust
6 · The paper itself

Abstract

Rare variants in ten genes have been reported to cause Mendelian sleep conditions characterised by extreme sleep duration or timing. These include familial natural short sleep (ADRB1, DEC2/BHLHE41, GRM1 and NPSR1), advanced sleep phase (PER2, PER3, CRY2, CSNK1D and TIMELESS) and delayed sleep phase (CRY1). The association of variants in these genes with extreme sleep conditions were usually based on clinically ascertained families, and their effects when identified in the population are unknown. We aimed to determine the effects of these variants on sleep traits in large population-based cohorts. We performed genetic association analysis of variants previously reported to be causal for Mendelian sleep and circadian conditions. Analyses were performed using 191,929 individuals with data on sleep and whole-exome or genome-sequence data from 4 population-based studies: UK Biobank, FINRISK, Health-2000-2001, and the Multi-Ethnic Study of Atherosclerosis (MESA). We identified sleep disorders from self-report, hospital and primary care data. We estimated sleep duration and timing measures from self-report and accelerometery data. We identified carriers for 10 out of 12 previously reported pathogenic variants for 8 of the 10 genes. They ranged in frequency from 1 individual with the variant in CSNK1D to 1,574 individuals with a reported variant in the PER3 gene in the UK Biobank. No carriers for variants reported in NPSR1 or PER2 were identified. We found no association between variants analyzed and extreme sleep or circadian phenotypes. Using sleep timing as a proxy measure for sleep phase, only PER3 and CRY1 variants demonstrated association with earlier and later sleep timing, respectively; however, the magnitude of effect was smaller than previously reported (sleep midpoint ~7 mins earlier and ~5 mins later, respectively). We also performed burden tests of protein truncating (PTVs) or rare missense variants for the 10 genes. Only PTVs in PER2 and PER3 were associated with a relevant trait (for example, 64 individuals with a PTV in PER2 had an odds ratio of 4.4 for being "definitely a morning person", P = 4x10-8; and had a 57-minute earlier midpoint sleep, P = 5x10-7). Our results indicate that previously reported variants for Mendelian sleep and circadian conditions are often not highly penetrant when ascertained incidentally from the general population.

Indexed as

Circadian RhythmSleep Wake DisordersHumansPhenotypeReceptors, G-Protein-CoupledSleepNPSR1 protein, humanReceptors, G-Protein-Coupled

Identifiers

PMID36137075
PMCPMC9499244
OpenAlexW4296803617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.